Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

General Electric Stock May Double Despite Aerospace Woes

By Chris Lau, InvestorPlace Contributor

The aerospace division will weigh on GE stock for a while longer, but it will be offset by a big asset sale and healthcare machinery demand.

Plug Power Stock Rests on the Success of Its 2024 Plan

By Chris Lau, InvestorPlace Contributor

PLUG stock is holding up well despite the market downtrend, and investors are allowing the company to accumulate near-term losses.

Inovio Is Still Hot as the Coronavirus Spreads

By Chris Lau, InvestorPlace Contributor

INO stock still has some serious upside, thanks to its INO-4800. Inovio's coronavirus vaccine takes the lead and is in preclinical trials.

7 Stocks to Buy Once the Market Bottoms

By Chris Lau, InvestorPlace Contributor

Look for stocks to buy when the market hits a bottom and these big companies offer discounted prices and huge growth ahead.

Microsoft Stock Will Prevail Despite Slowing PC Sales

By Chris Lau, InvestorPlace Contributor

Microsoft stock is boosted by more than just Windows and Surface PC sales, as Azure and other cloud software still lead its growth.

Load More